» Articles » PMID: 34334364

Autoantibodies Against Unmodified and Citrullinated Human Endogenous Retrovirus K Envelope Protein in Patients With Rheumatoid Arthritis

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2021 Aug 2
PMID 34334364
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Autoantibodies against proteins encoded by human endogenous retrovirus K (HERV-K) have been reported in patients with rheumatoid arthritis (RA), but their relevance, if any, has remained unresolved. We revisited this question and tested if such autoantibodies may react with citrullinated epitopes on the envelope (Env) protein of HERV-K.

Methods: Immunoblotting and ELISAs were conducted with unmodified Env protein and with Env citrullinated by protein arginine deiminase 4 (PAD4). Sera from 100 patients with RA, plasma from 32 patients with juvenile idiopathic arthritis (JIA), and healthy adult and pediatric controls were included. Antibody reactivity was evaluated for correlations with clinical and laboratory variables of the patients.

Results: We replicated and expanded upon published data suggesting that patients with RA or JIA have autoantibodies against HERV-K Env, some with high titers. Anti-HERV-K antibodies correlated with cigarette smoking and with circulating myeloperoxidase-DNA complexes indicative of nonapoptotic neutrophil cell death. Further, most of the patients with RA, but not those with JIA, had autoantibodies that reacted more strongly with Env that was citrullinated by PAD4. These anticitrullinated Env autoantibodies correlated with seropositivity and tended to be higher in patients with erosive disease.

Conclusion: Our data suggest that anti-HERV-K immunity is elevated in RA and JIA and may have a connection with pathogenic protein citrullination in RA.

Citing Articles

Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer.

Gong Q, Xu R Front Immunol. 2025; 15:1533740.

PMID: 39850893 PMC: 11754298. DOI: 10.3389/fimmu.2024.1533740.


Antibodies against endogenous retroviruses.

Chisca M, Larouche J, Xing Q, Kassiotis G Immunol Rev. 2024; 328(1):300-313.

PMID: 39152687 PMC: 11659944. DOI: 10.1111/imr.13378.


The peculiar features, diversity and impact of citrulline-reactive autoantibodies.

Raposo B, Klareskog L, Robinson W, Malmstrom V, Gronwall C Nat Rev Rheumatol. 2024; 20(7):399-416.

PMID: 38858604 DOI: 10.1038/s41584-024-01124-6.


HERVs: Expression Control Mechanisms and Interactions in Diseases and Human Immunodeficiency Virus Infection.

Mantovani F, Kitsou K, Magiorkinis G Genes (Basel). 2024; 15(2).

PMID: 38397182 PMC: 10888493. DOI: 10.3390/genes15020192.


Expression of Envelope Protein Encoded by Endogenous Retrovirus K102 in Rheumatoid Arthritis Neutrophils.

Laine A, Wang X, Ni K, Smith S, Najjar R, Whitmore L Microorganisms. 2023; 11(5).

PMID: 37317284 PMC: 10223813. DOI: 10.3390/microorganisms11051310.


References
1.
Bhardwaj N, Maldarelli F, Mellors J, Coffin J . HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. J Virol. 2014; 88(19):11108-20. PMC: 4178833. DOI: 10.1128/JVI.01623-14. View

2.
Duvvuri B, Pachman L, Morgan G, Khojah A, Klein-Gitelman M, Curran M . Neutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis. Arthritis Rheumatol. 2019; 72(2):348-358. DOI: 10.1002/art.41078. View

3.
Raijmakers R, van Beers J, El-Azzouny M, Visser N, Bozic B, Pruijn G . Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res Ther. 2012; 14(3):R114. PMC: 3446491. DOI: 10.1186/ar3840. View

4.
Yamada R . Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis. Autoimmun Rev. 2005; 4(4):201-6. DOI: 10.1016/j.autrev.2004.11.002. View

5.
Mustelin T, Bottini N, Stanford S . The Contribution of PTPN22 to Rheumatic Disease. Arthritis Rheumatol. 2018; 71(4):486-495. PMC: 6438733. DOI: 10.1002/art.40790. View